IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $231,000 | -20.9% | 5,156 | 0.0% | 0.00% | – |
| Q4 2020 | $292,000 | +15.9% | 5,156 | 0.0% | 0.00% | – |
| Q3 2020 | $252,000 | -58.7% | 5,156 | -50.0% | 0.00% | -100.0% |
| Q2 2020 | $610,000 | +147.0% | 10,312 | +100.0% | 0.00% | 0.0% |
| Q1 2020 | $247,000 | -20.6% | 5,156 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $311,000 | +0.6% | 5,156 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $309,000 | -6.9% | 5,156 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $332,000 | -95.9% | 5,156 | -94.8% | 0.00% | -94.1% |
| Q1 2019 | $8,053,000 | -51.5% | 99,188 | -67.7% | 0.02% | +21.4% |
| Q4 2018 | $16,596,000 | +51.8% | 306,930 | +44.8% | 0.01% | +16.7% |
| Q3 2018 | $10,932,000 | +289.7% | 211,954 | +214.9% | 0.01% | +71.4% |
| Q2 2018 | $2,805,000 | +6.5% | 67,314 | +12.6% | 0.01% | +16.7% |
| Q1 2018 | $2,634,000 | +2482.4% | 59,760 | +1275.1% | 0.01% | – |
| Q2 2016 | $102,000 | +15.9% | 4,346 | +100.0% | 0.00% | – |
| Q1 2016 | $88,000 | -20.7% | 2,173 | +20.7% | 0.00% | – |
| Q4 2015 | $111,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |